Purchase Order 36C24221P1134
- Not listed
- This is a firm fixed-price purchase order awarded by the Department of Veterans Affairs (VA) Veterans Health Administration to Optum Pharmacy 601, LLC, a subsidiary of UnitedHealth Group Incorporated. The $113,491.93 award is for the provision of chemotherapy IV medications to support veterans' healthcare programs. Optum Pharmacy 601 is the prime contractor and is responsible for performing the work from their location in Brandon, Florida. The contract has no set-aside designation and was...
- This is a firm fixed-price purchase order awarded by the Department of Veterans Affairs (VA) Veterans Health Administration to Optum Pharmacy 601, LLC, a subsidiary of UnitedHealth Group Incorporated, to provide $1,775,720.00 in emergency chemo compounding services. The contract is for the provision of sterile hazardous drug compounding, emergency compounding, chemotherapy IV medications, and maintenance of proper facilities and equipment for chemotherapy treatment to support VA healthcare...
- This federal contract award was made by the Department of Veterans Affairs Veterans Health Administration to Optum Pharmacy 601, LLC, a subsidiary of UnitedHealth Group Incorporated. The $251,754.51 firm fixed price purchase order is for chemo compounding services to support veterans healthcare programs. Optum Pharmacy 601 provides specialized pharmacy services from its location in Brandon, Florida, including sterile hazardous drug compounding, emergency compounding, and chemotherapy IV...
- This is a firm fixed price purchase order awarded by the Department of Veterans Affairs (VA) Veterans Health Administration to Optum Pharmacy 601, LLC, a subsidiary of UnitedHealth Group Incorporated. The contract is for the provision of emergency pharmacy compounding services, including sterile hazardous drug compounding, emergency compounding, and chemotherapy IV medications, to support VA healthcare programs. The contract has a potential value of $389,267.85 and a completion date of September...
- This federal contract was awarded by the Department of Veterans Affairs' Veterans Health Administration to Optum Pharmacy 601, LLC, a subsidiary of UnitedHealth Group Incorporated, to provide compounding pharmacy and chemotherapy services in support of veterans healthcare programs. The contract has a firm fixed price of $181,672.00 and a completion date of January 13, 2021. Optum Pharmacy 601 is the prime contractor responsible for performing these specialized pharmaceutical services from...
- This is a firm fixed price purchase order awarded to Optum Pharmacy 601, LLC, a subsidiary of UnitedHealth Group Incorporated, by the Department of Veterans Affairs' Veterans Health Administration. The contract is for the provision of emergency compound prescription services, which include sterile hazardous drug compounding, emergency compounding, and chemotherapy IV medications. The contract is valued at $286,350.00 and has a completion date of September 30, 2020. Optum Pharmacy 601 has been...
- This is a firm fixed-price Blanket Purchase Agreement (BPA) call awarded by the Veterans Integrated Service Network 2 (VISN 2) of the U.S. Department of Veterans Affairs (VA) to Optum Pharmacy 601, LLC, a subsidiary of UnitedHealth Group Incorporated. The contract is for $84,822.20 and provides chemotherapy compound drug hood services. The contract has an ultimate completion date of November 19, 2025. Optum Pharmacy 601, LLC is a for-profit limited liability company that specializes in providing...
- The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 2 awarded a Blanket Purchase Agreement call contract to Optum Pharmacy 601, LLC for chemotherapy compound drug hood services. As the prime contractor, Optum Pharmacy 601, LLC, a subsidiary of UnitedHealth Group Incorporated, will provide these services at a location in Brandon, Florida. The potential value of the contract is $0.00 and it has a completion date of September 30, 2023. The pricing...
- This is a $55,205.54 firm fixed-price purchase order awarded by the U.S. Department of Veterans Affairs (VA) to Optum Pharmacy 801, Inc., a subsidiary of UnitedHealth Group Incorporated, to provide custom-dosed chemotherapy IV medications for the VA Baltimore Medical Center. The contract has a performance period through June 30, 2025. This requirement was competed on a full and open basis, without any set-aside designations. Optum Pharmacy 801, Inc., operating as Avella Specialty Pharmacy, has...
- This is a $82,038.47 firm fixed-price purchase order awarded by the Department of Veterans Affairs (VA) to Optum Pharmacy 601, LLC, a subsidiary of UnitedHealth Group that specializes in providing pharmacy services to the VA and Veterans Health Administration (VHA). The award is for emergency procurement of compound prescriptions, with an ultimate completion date of February 4, 2020. The contract is not set-aside. Optum Pharmacy 601 holds several VA/VHA indefinite delivery contracts and...
This is a firm fixed price purchase order awarded by the Department of Veterans Affairs (VA) Veterans Health Administration to Optum Pharmacy 601, LLC, a subsidiary of UnitedHealth Group Incorporated, for the provision of pharmacy chemo compound drug services. The contract has a completion date of September 30, 2021 and a potential value of $199,623.94. The contract was awarded on July 9, 2021 without the use of a set-aside. Optum Pharmacy 601 is the prime contractor responsible for performing the specialized pharmacy services, including sterile hazardous drug compounding, emergency compounding, chemotherapy IV medications, and maintenance of proper facilities and equipment for chemotherapy treatment, from their location in Brandon, Florida. This award is part of Optum Pharmacy 601's broader portfolio of federal contracts with the VA to provide compounding pharmacy and chemotherapy services in support of veterans healthcare programs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00002 | Funding Only Action | ($376) | 3/2/22 | |
| P00001 | Funding Only Action | $100.0k | 8/3/21 | |
| Not listed | Not listed | $100.0k | 7/9/21 |